Finance

Beta
Lists
6090:TYO
Human Metabolome Technologies Inc
¥617.00
+2.83%
(+17.00) 1D
Jun 5, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 6090...
Open
¥600
High
¥617
Low
¥600
Mkt. cap
3.65B
Avg. vol.
10.55K
Volume
17.90K
Dividend
2.43%
Quarterly dividend
¥4
Ex-dividend date
Jun 29, 2026
P/E ratio
28.98
52-wk high
¥869
52-wk low
¥581
EPS
¥21
Shares outstanding
5.85M
No. of employees
62
Open
¥600
High
¥617
Low
¥600
Mkt. cap
3.65B
Avg. vol.
10.55K
Volume
17.90K
Dividend
2.43%
Quarterly dividend
¥4
Ex-dividend date
Jun 29, 2026
P/E ratio
28.98
52-wk high
¥869
52-wk low
¥581
EPS
¥21
Shares outstanding
5.85M
No. of employees
62
News stories
From sources across the web
About Human Metabolome Technologies Inc
CEO-
Employees62
FoundedJul 1, 2003
Headquarters-
SectorHealth care
Websitehumanmetabolome.com
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
189.00M
192.00M
467.00M
448.00M
Cost of goods sold
114.00M
116.00M
162.00M
129.00M
Cost of revenue
114.00M
116.00M
162.00M
129.00M
Research and development expenses
177.00M
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-6.00M
167.00M
167.00M
157.00M
Operating expense
179.00M
167.00M
167.00M
157.00M
Total operating expenses
293.00M
283.00M
329.00M
286.00M
Operating income
-104.00M
-91.00M
138.00M
162.00M
Other non operating income
2.00M
-
-
-1.00M
EBT including unusual items
-98.00M
-73.00M
137.00M
162.00M
EBT excluding unusual items
-101.00M
-90.00M
137.00M
162.00M
Income tax expense
-50.00M
24.00M
-3.00M
40.00M
Effective tax rate
51.02%
-32.88%
-2.19%
24.69%
Other operating expenses
-
-
-
-
Net income
-48.00M
-97.00M
140.00M
122.00M
Net profit margin
-25.40%
-50.52%
29.98%
27.23%
Earnings per share
-
-
-
-
Interest and investment income
-
1.00M
-
1.00M
Interest expense
-
-
-1.00M
-
Net interest expenses
-
1.00M
-1.00M
1.00M
Depreciation and amortization charges
8.00M
-
-
-
EBITDA
-78.25M
-65.25M
165.50M
187.75M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer